Thiothixene

Applications

NDAs, BLAs and generic ANDAs for this ingredient, oldest first; each opens its full history

Approved	Application	Sponsor	Supplements	Marketing
Jul 24, 1967	NavaneNDA 16584 · New molecular entity	Pfizer	28	Discontinued
Jun 5, 1987	ThiothixeneANDA 70600	Chartwell Rx	14	Discontinued
Jun 5, 1987	ThiothixeneANDA 70601	Chartwell Rx	15	Discontinued
Jun 5, 1987	ThiothixeneANDA 70602	Chartwell Rx	14	Discontinued
Jun 5, 1987	ThiothixeneANDA 70603	Chartwell Rx	14	Discontinued
Jun 23, 1987	ThiothixeneANDA 71093	Rising	16	Marketed
Jun 24, 1987	ThiothixeneANDA 71529	Epic Pharma LLC	20	Discontinued
Jun 24, 1987	ThiothixeneANDA 71530	Sandoz	18	Discontinued
Apr 5, 2019	ThiothixeneANDA 211642	Novitium Pharma	1	Marketed
Feb 28, 2022	ThiothixeneANDA 215456	Amneal	1	Marketed
—	ThiothixeneANDA 71626	Watson Labs	0	Discontinued
—	ThiothixeneANDA 71627	Watson Labs	0	Discontinued
—	ThiothixeneANDA 71628	Watson Labs	0	Discontinued
—	ThiothixeneANDA 71884	Am Therap	0	Discontinued
—	ThiothixeneANDA 71885	Am Therap	0	Discontinued
—	ThiothixeneANDA 71886	Am Therap	0	Discontinued
—	ThiothixeneANDA 71887	Am Therap	0	Discontinued
—	ThiothixeneANDA 72200	Am Therap	0	Discontinued

Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA